Genomic aberrations in 80 cases of primary glioblastoma multiforme: Pathogenetic heterogeneity and putative cytogenetic pathways

Genes Chromosomes and Cancer

Volumn 48, Issue 10, 2009, Pages 908-924

  Dahlback, Hanne Sofie S ^a,b   Brandal, Petter ^a   Meling, Torstein R ^a   Gorunova, Ludmila ^a   Scheie, David ^a   Heim, Sverre ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 1; CHROMOSOME 12Q; CHROMOSOME 19Q; CHROMOSOME 22Q; CHROMOSOME 3; CHROMOSOME 3Q; CHROMOSOME 6Q; CHROMOSOME 9; CHROMOSOME BANDING PATTERN; CHROMOSOME G BAND; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENETIC HETEROGENEITY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MONOSOMY; NUMERICAL CHROMOSOME ABERRATION; PATHOGENESIS; PRIMARY TUMOR; PRIORITY JOURNAL; RING CHROMOSOME; STRUCTURAL CHROMOSOME ABERRATION; TRISOMY 7;

ADOLESCENT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GLIOBLASTOMA; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 70349330124     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20690     Document Type: Article

References (64)

1. Actor B, Cobbers JM, Buschges R, Wolter M, Knobbe CB, Lichter P, Reifenberger G, Weber RG. 2002. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Genes Chromosomes Cancer 34:416-427. (Pubitemid 34787463)
2. Arslantas A, Artan S, Oner U, Muslumanoglu MH, Ozdemir M, Durmaz R, Arslantas D, Vural M, Cosan E, Atasoy MA. 2007. Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas. Pathol Oncol Res 13:39-46. (Pubitemid 46883545)
3. Baudis M. 2009. Progenetix - Cytogenetic abnormalities in human cancer. Available at: www.progenetix.net. (accessed April 30, 2009)
4. Bigner SH, Mark J, Bullard DE, Mahaley MS, Jr., Bigner DD. 1986. Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations. Cancer Genet Cytogenet 22:121-135. (Pubitemid 16040864)
5. Bigner SH, Mark J, Burger PC, Mahaley MS, Jr., Bullard DE, Muhlbaier LH, Bigner DD. 1988. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48:405-411. (Pubitemid 18045778)
6. Bigner SH, Mark J, Bigner DD. 1990. Cytogenetics of human brain tumors. Cancer Genet Cytogenet 47:141-154.
7. Bigner SH, Vogelstein B. 1990. Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathol 1:12-18.
8. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN. 1998. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473-1479. (Pubitemid 28482012)
9. Campbell PJ, Stephens PJ, Pleasance ED, O'Meara S, Li H, Santarius T, Stebbings LA, Leroy C, Edkins S, Hardy C, Teague JW, Menzies A, Goodhead I, Turner DJ, Clee CM, Quail MA, Cox A, Brown C, Durbin R, Hurles ME, Edwards PA, Bignell GR, Stratton MR, Futreal PA. 2008. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40:722-729. (Pubitemid 351748860)
10. Colman H, Aldape K. 2008. Molecular predictors in glioblastoma: Toward personalized therapy. Arch Neurol 65:877-883. (Pubitemid 352008470)
11. Cotran RS, Kumar V, Collins T. 1999. Robbins Pathologic Basis of Disease, 6th ed. Philadelphia: W.B. Saunders Company.
12. de Ståhl T, Hartmann C, de Bustos C, Piotrowski A, Benetkiewicz M, Mantripragada K, Tykwinski T, von Deimling A, Dumanski J. 2005. Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme. Genes Chromosomes Cancer 44:161-169. (Pubitemid 41306644)
13. de Tayrac M, Etcheverry A, Aubry M, Saikali S, Hamlat A, Quillien V, Le Treut A, Galibert MD, Mosser J. 2009. Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression. Genes Chromosomes Cancer 48:55-68.
14. Debiec-Rychter M, Alwasiak J, Liberski PP, Nedoszytko B, Babinska M, Mrozek K, Imielinski B, Borowska-Lehman J, Limon J. 1995. Accumulation of chromosomal changes in human glioma progression. Cancer Genet Cytogenet 85:61-67.
15. Druker BJ. 2008. Translation of the Philadelphia chromosome into therapy for CML. Blood 112:4808-4817.
16. Hartmann C, Nümann A, Mueller W, Holtkamp N, Simon M, von Deimling A. 2004. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. Int J Cancer 108:839-844. (Pubitemid 38112611)
17. Hassler M, Seidl S, Fazeny-Doerner B, Preusser M, Hainfellner J, Rossler K, Prayer D, Marosi C. 2006. Diversity of cytogenetic and pathohistologic profiles in glioblastoma. Cancer Genet Cytogenet 166:46-55.
18. Hecht BK, Turc-Carel C, Chatel M, Grellier P, Gioanni J, Attias R, Gaudray P, Hecht F. 1995. Cytogenetics of malignant gliomas. I. The autosomes with reference to rearrangements. Cancer Genet Cytogenet 84:1-8.
19. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R. 2005. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003. (Pubitemid 40349502)
20. Heim S, Mitelman F. 2009. Cancer Cytogenetics, 3rd ed. New Jersey: Wiley-Blackwell.
21. Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM. 2008. Characterization of TMPRSS2:ETV5 and SLC45A3: ETV5 gene fusions in prostate cancer. Cancer Res 68:73-80.
22. Ichimura K, Schmidt EE, Goike HM, Collins VP. 1996. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13:1065-1072. (Pubitemid 26329093)
23. Ichimura K, Vogazianou AP, Liu L, Pearson DM, Backlund LM, Plant K, Baird K, Langford CF, Gregory SG, Collins VP. 2008. 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas. Oncogene 27:2097-2108.
24. Idbaih A, Marie Y, Pierron G, Brennetot C, Hoang-Xuan K, Kujas M, Mokhtari K, Sanson M, Lejeune J, Aurias A, Delattre O, Delattre JY. 2005. Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 58:483-487. (Pubitemid 41266639)
25. ISCN. 2005. An international system for human cytogenetic nomenclature. Basel, Switzerland: S. Karger Publishers.
26. Jenkins RB, Kimmel DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW. 1989. A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39:253-279.
27. Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC. 2006. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66:9852-9861. (Pubitemid 44672036)
28. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
29. Kirchhoff M, Gerdes T, Rose H, Maahr J, Ottesen AM, Lundsteen C. 1998. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry 31:163-173. (Pubitemid 28113896)
30. Kirchhoff M, Gerdes T, Maahr J, Rose H, Bentz M, Dohner H, Lundsteen C. 1999. Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals. Genes Chromosomes Cancer 25:410-413. (Pubitemid 29326152)
31. Kraggerud SM, Szymanska J, Abeler VM, Kaern J, Eknaes M, Heim S, Teixeira MR, Trope CG, Peltomaki P, Lothe RA. 2000. DNA copy number changes in malignant ovarian germ cell tumors. Cancer Res 60:3025-3030. (Pubitemid 30395830)
32. Lindstrom E, Salford LG, Heim S, Mandahl N, Stromblad S, Brun A, Mitelman F. 1991. Trisomy 7 and sex chromosome loss need not be representative of tumor parenchyma cells in malignant glioma. Genes Chromosomes Cancer 3:474-479.
33. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. 2007. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109.
34. Mandahl N. 1992. Methods in solid tumors cytogenetics. In: Rooney DE, Czepulkowski BH, editors. Human Cytogenetics-A Practical Approach: Malignancy and Acquired Abnormalities, Vol.II. Oxford: IRL Press.
35. Margetts JC, Kalyan-Raman UP. 1989. Giant-celled glioblastoma of brain. A clinico-pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure). Cancer 63:524-531.
36. Mitelman F, Johansson B, Mertens F, editors. 2009. Mitelman database of chromosome aberrations in cancer. Available at http://cgap.nci.nih.gov/ Chromosomes/Mitelman (accessed April 30, 2009).
37. Mohapatra G, Bollen AW, Kim DH, Lamborn K, Moore DH, Prados MD, Feuerstein BG. 1998. Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade. Genes Chromosomes Cancer 21:195-206. (Pubitemid 28136436)
38. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P. 2004. Genetic pathways to glioblastoma: A population-based study. Cancer Res 64:6892-6899. (Pubitemid 39330996)
39. Ohgaki H, Kleihues P. 2007. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445-1453. (Pubitemid 47339290)
40. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr., Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812.
41. Pinto LW, Araujo MB, Vettore AL, Wernersbach L, Leite AC, Chimelli LM, Soares FA. 2008. Glioblastomas: Correlation between oligodendroglial components, genetic abnormalities, and prognosis. Virchows Arch 452:481-490.
42. Pruchon E, Chauveinc L, Sabatier L, Dutrillaux A, Ricoul M, Delattre J, Vega F, Poisson M, Hor F, Dutrillaux B. 1994. A cytogenetic study of 19 recurrent gliomas. Cancer Genet Cytogenet 76:85-92.
43. Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD, Bigner SH. 1995. Chromosome 10 deletion mapping in human gliomas: A common deletion region in 10q25. Oncogene 10:2243-2246.
44. Ribeiro FR, Jeronimo C, Henrique R, Fonseca D, Oliveira J, Lothe RA, Teixeira MR. 2006. 8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects. Clin Cancer Res 12:3961-3970. (Pubitemid 44078081)
45. Rossi MR, La Duca J, Matsui S, Nowak NJ, Hawthorn L, Cowell JK. 2005. Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition to EGFR in glioblastoma multiforme. Genes Chromosomes Cancer 44:392-404. (Pubitemid 41476790)
46. Roversi G, Pfundt R, Moroni RF, Magnani I, van Reijmersdal S, Pollo B, Straatman H, Larizza L, Schoenmakers EF. 2006. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines. Oncogene 25:1571-1583. (Pubitemid 43361942)
47. Ruano Y, Mollejo M, Ribalta T, Fiano C, Camacho FI, Gomez E, de Lope AR, Hernandez-Moneo JL, Martinez P, Melendez B. 2006. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer 5:39. (Pubitemid 44541842)
48. Schlegel J, Scherthan H, Arens N, Stumm G, Kiessling M. 1996. Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization. J Neuropathol Exp Neurol 55:81-87. (Pubitemid 26013788)
49. Schrock E, Thiel G, Lozanova T, du Manoir S, Meffert MC, Jauch A, Speicher MR, Nurnberg P, Vogel S, Janisch W, Donis-Keller H, Ried T, Witkowski R, Cremer T. 1994. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144:1203-1218.
50. Seng TJ, Ichimura K, Liu L, Tingby O, Pearson DM, Collins VP. 2005. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Genes Chromosomes Cancer 43:181-193. (Pubitemid 40570738)
51. Shinojima N, Kochi M, Hamada J, Nakamura H, Yano S, Makino K, Tsuiki H, Tada K, Kuratsu J, Ishimaru Y, Ushio Y. 2004. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme. J Neurosurg 101:219-226. (Pubitemid 38970996)
52. Skotheim RI, Thomassen GO, Eken M, Lind GE, Micci F, Ribeiro FR, Cerveira N, Teixeira MR, Heim S, Rognes T, Lothe RA. 2009. A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis. Mol Cancer 8:5.
53. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996.
54. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. 2009. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 6:6.
55. Teixeira MR, Ribeiro FR, Eknaes M, Waehre H, Stenwig AE, Giercksky KE, Heim S, Lothe RA. 2004. Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making. Cancer 101:1786-1793. (Pubitemid 39314741)
56. The Cancer Genome Atlas Research Network. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068.
57. Thiel G, Losanowa T, Kintzel D, Nisch G, Martin H, Vorpahl K, Witkowski R. 1992. Karyotypes in 90 human gliomas. Cancer Genet Cytogenet 58:109-120.
58. United Kingdom Cancer Cytogenetics Group. 1992. Loss of the Y chromosome from normal and neoplastic bone marrows. Genes Chromosomes Cancer 5:83-88.
59. Vranova V, Necesalova E, Kuglik P, Cejpek P, Pesakova M, Budinska E, Relichova J, Veselska R. 2007. Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization. Oncol Rep 17:457-464.
60. Watanabe K, Nagai M, Wakai S, Arai T, Kawashima K. 1990. Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma. Acta Neuropathol 80:251-254. (Pubitemid 20220538)
61. Weber RG, Sommer C, Albert FK, Kiessling M, Cremer T. 1996. Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab Invest 74:108-119. (Pubitemid 26041013)
62. Wiltshire RN, Rasheed BK, Friedman HS, Friedman AH, Bigner SH. 2000. Comparative genetic patterns of glioblastoma multiforme: Potential diagnostic tool for tumor classification. Neuro Oncol 2:164-173.
63. Wiltshire RN, Herndon JE, 2nd, Lloyd A, Friedman HS, Bigner DD, Bigner SH, McLendon RE. 2004. Comparative genomic hybridization analysis of astrocytomas: Prognostic and diagnostic implications. J Mol Diagn 6:166-179.
64. World Health Organization. 2007. WHO Classification of Tumours of the Central Nervous System, 4th ed. Renouf.